Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kineret for inflammatory biomarkers after subarachnoid haemorrhage
ISRCTN46365506Phase 4Completed
- Sponsor
- Northern Care Alliance
- Start
- Jun 2009
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Kineret with Placebo (2 arms). Primary endpoint: Change in inflammatory biomarkers in blood and cerebrospinal fluid. Started Jun 2009; status: completed.
02
Drugs
anakinra
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on ISRCTN46365506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN46365506.